Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

WHITE BEAR LAKE, Minnesota , April 03, 2024 (GLOBE NEWSWIRE) -- Envoy Medical, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will present a corporate overview at the LD Micro Invitational XIV 2024.  The conference is being held on April 8 - 9, 2024 at the Sofitel Hotel in New York City.

Presentation Date:             Tuesday, April 9, 2024

Time:                                    2:30pm ET (Track 3 – St. Germain III)

Register below to view the presentation:
https://ldinv14.sequireevents.com/

Mr. Lucas and Mr. Wells will be holding one-on-one meetings with registered investors and analysts at the conference to discuss recent events and updates on clinical trials.  To schedule a one-on-one meeting, please contact Dean Summers at LD Micro ([e-mail]) or CORE IR ([e-mail]).

About the Fully Implanted Acclaim Cochlear Implant

We believe the fully implanted Acclaim Cochlear Implant (“Acclaim CI”) will be a first-of-its-kind fully implanted cochlear implant. Envoy Medical’s fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound.

The Acclaim CI is designed to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids. The Acclaim CI is expected to be indicated for adults who have been deemed adequate candidates by a qualified physician.

The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019. We believe the Acclaim CI was the first hearing-focused device to receive Breakthrough Device Designation.

CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by United States law to investigational use.

About the Esteem Fully Implanted Active Middle Ear Implant (FI-AMEI)

The Esteem fully implanted active middle ear implant (FI-AMEI) is the only FDA-approved, fully implanted* hearing device for adults diagnosed with moderate to severe sensorineural hearing loss allowing for 24/7 hearing capability using the ear’s natural anatomy.  The Esteem FI-AMEI hearing implant is invisible and requires no externally worn components and nothing is placed in the ear canal for it to function.  Unlike hearing aids, you never put it on or take it off. You can’t lose it. You don’t clean it. The Esteem FI-AMEI hearing implant offers true 24/7 hearing.